REQUEST A DEMO
Total
USD $0.00
Search more companies

Db Biotech, A.S. (Slovakia)

Main Activities: Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: General Merchandise Stores, including Warehouse Clubs and Supercenters
Full name: Db Biotech, A.S. Profile Updated: July 07, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Db Biotech, A.S. is based in Slovakia, with the head office in Kosice. The enterprise currently operates in the Research and Development in Nanotechnology sector. Db Biotech, A.S. was incorporated on May 10, 2006. The total number of employees is currently 5 - 9 (2025). From the latest financial highlights, Db Biotech, A.S. reported a net sales revenue drop of 19.43% in 2024. Its’ total assets recorded a negative growth of 5.28%. Db Biotech, A.S.’s net profit margin increased by 2.77% in 2024.

Headquarters
Popradska, 80
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Db Biotech, A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Db Biotech, A.S. report to view the information.
Registered Capital:
Purchase the Db Biotech, A.S. report to view the information.
Financial Auditors:
Purchase the Db Biotech, A.S. report to view the information.
Incorporation Date:
May 10, 2006
Key Executives
Purchase this report to view the information.
Chairman of the Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Company Performance
Financial values in the chart are available after Db Biotech, A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-19.43%
Total operating revenue
-16.93%
Operating profit (EBIT)
49.81%
EBITDA
53.26%
Net Profit (Loss) for the Period
34.09%
Total assets
-5.28%
Total equity
-16.03%
Operating Profit Margin (ROS)
5.29%
Net Profit Margin
2.77%
Return on Equity (ROE)
5.23%
Debt to Equity Ratio
-0.44%
Quick Ratio
-0.01%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?